Sarah Finer

Sarah Finer

Auto-generated profile, based on publicly available information

Sarah Finer

Affiliation Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2010 in Genome Research
Verified
Journal Article
Open access
PDF file
VRVardhman K. Rakyan
Vardhman K. Rakyan
TDThomas A. Down
Thomas A. Down
SMSiarhei Maslau
Siarhei Maslau
TAToby Andrew
Toby Andrew
TYTsun-Po Yang
Tsun-Po Yang
TSTimothy D. Spector
Timothy D. Spector
There is a growing realization that some aging-associated phenotypes/diseases have an epigenetic basis. Here, we report the first genome-scale study of epigenomic dynamics during normal human aging. We identify aging-associated differentially methylated regions (aDMRs) in whole blood in a discovery cohort, and then replicate these aDMRs in sorted CD4+ T-cells and CD14+ monocytes in an independent cohort, suggesting that aDMRs occur in precursor haematopoietic cells. Further replication of the aDMRs in buccal cells, representing a tissue that originates from a different germ layer compared with blood, demonstrates that the aDMR signature is a multitissue phenomenon. Moreover, we demonstrate that aging-associated DNA hypermethylation occurs predominantly at bivalent chromatin domain promoters. This same category of promoters, associated with key developmental genes, is frequently hypermethylated in cancers and in vitro cell culture, pointing to a novel mechanistic link between aberrant hypermethylation in cancer, aging, and cell culture.

18 November 2010 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CBChristopher Bell
Christopher Bell
SFSarah Finer
Sarah Finer
CLCecilia Lindgren
Cecilia Lindgren
GWGareth A. Wilson
Gareth A. Wilson
VRVardhman K. Rakyan
Vardhman K. Rakyan
GHGraham A. Hitman
Graham A. Hitman
Recent multi-dimensional approaches to the study of complex disease have revealed powerful insights into how genetic and epigenetic factors may underlie their aetiopathogenesis. We examined genotype-epigenotype interactions in the context of Type 2 Diabetes (T2D), focussing on known regions of genomic susceptibility. We assayed DNA methylation in 60 females, stratified according to disease susceptibility haplotype using previously identified association loci. CpG methylation was assessed using methylated DNA immunoprecipitation on a targeted array (MeDIP-chip) and absolute methylation values were estimated using a Bayesian algorithm (BATMAN). Absolute methylation levels were quantified across LD blocks, and we identified increased DNA methylation on the FTO obesity susceptibility haplotype, tagged by the rs8050136 risk allele A (p = 9.40×10−4, permutation p = 1.0×10−3). Further analysis across the 46 kb LD block using sliding windows localised the most significant difference to be within a 7.7 kb region (p = 1.13×10−7). Sequence level analysis, followed by pyrosequencing validation, revealed that the methylation difference was driven by the co-ordinated phase of CpG-creating SNPs across the risk haplotype. This 7.7 kb region of haplotype-specific methylation (HSM), encapsulates a Highly Conserved Non-Coding Element (HCNE) that has previously been validated as a long-range enhancer, supported by the histone H3K4me1 enhancer signature. This study demonstrates that integration of Genome-Wide Association (GWA) SNP and epigenomic DNA methylation data can identify potential novel genotype-epigenotype interactions within disease-associated loci, thus providing a novel route to aid unravelling common complex diseases.

4 January 2024 in Nature Genetics
Verified
Journal Article
Open access
PDF file
XMXiangrui Meng
Xiangrui Meng
GNGeorgina Navoly
Georgina Navoly
OGOlga Giannakopoulou
Olga Giannakopoulou
DLDaniel Levey
Daniel Levey
DKDora Koller
Dora Koller
BPBioBank Japan Project
BioBank Japan Project
Most genome-wide association studies (GWAS) of major depression (MD) have been conducted in samples of European ancestry. Here we report a multi-ancestry GWAS of MD, adding data from 21 cohorts with 88,316 MD cases and 902,757 controls to previously reported data. This analysis used a range of measures to define MD and included samples of African (36% of effective sample size), East Asian (26%) and South Asian (6%) ancestry and Hispanic/Latin American participants (32%). The multi-ancestry GWAS identified 53 significantly associated novel loci. For loci from GWAS in European ancestry samples, fewer than expected were transferable to other ancestry groups. Fine mapping benefited from additional sample diversity. A transcriptome-wide association study identified 205 significantly associated novel genes. These findings suggest that, for MD, increasing ancestral and global diversity in genetic studies may be particularly important to ensure discovery of core genes and inform about transferability of findings.

29 January 2015 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
SFSarah Finer
Sarah Finer
CMChris Mathews
Chris Mathews
RLRob Lowe
Rob Lowe
MSMelissa Smart
Melissa Smart
SHSara Hillman
Sara Hillman
GHGraham A Hitman
Graham A Hitman
Exposure of a developing foetus to maternal gestational diabetes (GDM) has been shown to programme future risk of diabetes and obesity. Epigenetic variation in foetal tissue may have a mechanistic role in metabolic disease programming through interaction of the pregnancy environment with gene function. We aimed to identify genome-wide DNA methylation variation in cord blood and placenta from offspring born to mothers with and without GDM. Pregnant women of South Asian origin were studied and foetal tissues sampled at term delivery. The Illumina HumanMethylation450 BeadChip was used to assay genome-wide DNA methylation in placenta and cord blood from 27 GDM exposed and 21 unexposed offspring. We identified 1485 cord blood and 1708 placenta methylation variable positions (MVPs) achieving genome-wide significance (adjusted P-value 5%. MVPs were disproportionately located within first exons. A bioinformatic co-methylation algorithm was used to detect consistent directionality of methylation in 1000 bp window around each MVP was observed at 74% of placenta and 59% of cord blood MVPs. KEGG pathway analysis showed enrichment of pathways involved in endocytosis, MAPK signalling and extracellular triggers to intracellular metabolic processes. Replication studies should integrate genomics and transcriptomics with longitudinal sampling to elucidate stability, determine causality for translation into biomarker and prevention studies.

28 August 2019 in International Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
SFSarah Finer
Sarah Finer
HMHilary C Martin
Hilary C Martin
AKAhsan Khan
Ahsan Khan
KHKaren A Hunt
Karen A Hunt
BMBeverley MacLaughlin
Beverley MacLaughlin
DHDavid A van Heel
David A van Heel
East London Genes & Health (ELGH) is a community based, long-term study of health and disease in British Bangladeshi and British Pakistani people in east London. ELGH has a population-based design incorporating cutting edge genomics with electronic health record (EHR) data linkage and targeted recall-by-genotype (RbG) studies. ELGH currently has 38 899 volunteers and is actively recruiting with funding to expand to 100 000 volunteers by 2023. ELGH is an open access data resource, and its research will impact upon a population at high need and will redress the poor representation of non-White ethnic groups in existing population genomic cohorts.1

26 February 2022 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
NPNatalia Pervjakova
Natalia Pervjakova
GMGunn-Helen Moen
Gunn-Helen Moen
MBMaria-Carolina Borges
Maria-Carolina Borges
TFTeresa Ferreira
Teresa Ferreira
JCJames P Cook
James P Cook
RMReedik Mägi
Reedik Mägi
Gestational diabetes mellitus (GDM) is associated with increased risk of pregnancy complications and adverse perinatal outcomes. GDM often reoccurs and is associated with increased risk of subsequent diagnosis of type 2 diabetes (T2D). To improve our understanding of the aetiological factors and molecular processes driving the occurrence of GDM, including the extent to which these overlap with T2D pathophysiology, the GENetics of Diabetes In Pregnancy Consortium assembled genome-wide association studies of diverse ancestry in a total of 5485 women with GDM and 347 856 without GDM. Through multi-ancestry meta-analysis, we identified five loci with genome-wide significant association (P < 5 × 10−8) with GDM, mapping to/near MTNR1B (P = 4.3 × 10−54), TCF7L2 (P = 4.0 × 10−16), CDKAL1 (P = 1.6 × 10−14), CDKN2A-CDKN2B (P = 4.1 × 10−9) and HKDC1 (P = 2.9 × 10−8). Multiple lines of evidence pointed to the shared pathophysiology of GDM and T2D: (i) four of the five GDM loci (not HKDC1) have been previously reported at genome-wide significance for T2D; (ii) significant enrichment for associations with GDM at previously reported T2D loci; (iii) strong genetic correlation between GDM and T2D and (iv) enrichment of GDM associations mapping to genomic annotations in diabetes-relevant tissues and transcription factor binding sites. Mendelian randomization analyses demonstrated significant causal association (5% false discovery rate) of higher body mass index on increased GDM risk. Our results provide support for the hypothesis that GDM and T2D are part of the same underlying pathology but that, as exemplified by the HKDC1 locus, there are genetic determinants of GDM that are specific to glucose regulation in pregnancy.